| Financial Year |
March 31 2023 |
| Monetary Funds |
478,034,709.32 |
| Held-for-trading Financial Assets |
91,000,000.00 |
| Notes Receivable |
2,600,000.00 |
| Accounts Receivable |
167,885,613.48 |
| Advances to Suppliers |
6,279,476.00 |
| Other Receivables |
2,037,770.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
323,338,599.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,400,006.41 |
| Total Current Assets |
1,090,586,438.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
892,461,752.29 |
| Under-construction Projects |
95,300,478.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
98,212,949.30 |
| R&D expenses |
34,067,804.58 |
| Goodwill |
156,336,178.69 |
| Long-Term Deferred and Prepaid Expenses |
4,989,861.06 |
| Deferred Income Tax Assets |
26,558,277.60 |
| Other Non-Current Assets |
98,884,557.47 |
| Sub-Total of Non-Current Assets |
1,502,113,796.17 |
| Total Assets |
2,592,700,235.07 |
| Short-Term Loans |
418,675,019.46 |
| Trading Financial liabilities |
359,504.49 |
| Notes Payable |
45,973,239.99 |
| Accounts Payable |
101,073,368.31 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,527,489.86 |
| Taxes Payable |
3,969,782.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,769,173.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
202,044.38 |
| Other Current Liabilities |
3,212,006.43 |
| Sub-Total of Current Liabilities |
604,120,687.19 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,462,559.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
44,574,787.05 |
| Total Liabilities |
648,695,474.24 |
| Paid-In Capital(Or Share Stock) |
213,183,800.00 |
| Capital Surplus |
1,318,761,728.22 |
| Surplus Reserve |
14,999,476.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
380,959,975.32 |
| Minority Stockholder's Interest |
12,533,102.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,931,471,658.69 |
| Owner's Equity（Stockholder's Equity） |
1,944,004,760.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,592,700,235.07 |
